Introduction
In angiogenesis, new blood vessels develop from existing endothelium in response to angiogenic stimuli. These blood vessels are crucial for organ growth during embryonic development and tissue regeneration in the adult. In many diseases, the body loses control over angiogenesis, leading to an imbalance in the growth of blood vessels. This imbalance results in either excessive angiogenesis, occurring in diseases such as cancer, diabetic blindness, and age-related macular degeneration, or insufficient angiogenesis, occurring in diseases such as coronary artery disease and stroke. 1 Angiogenic growth factors of the vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) families stimulate essential signalling pathways in vascular development and control both physiological and pathological angiogenesis in the adult. Different components of these pathways have been put forward as targets for anti-angiogenic therapies for cancer, and for pro-angiogenic therapies for vascular occlusive diseases. 2, 3 Unfortunately, these cytokine-based approaches did not lead to the expected results.
Although the proteins and pathways controlling angiogenesis and vascular development are well studied, the modulation of angiogenic signalling cascades by microRNAs (miRNAs) is not well understood. miRNAs are short, non-coding RNAs that regulate gene expression through translational repression or degradation of target messenger RNA (mRNA), resulting in the fine-tuning of gene expression. 4 miRNAs are increasingly seen as master regulators of many processes, including angiogenesis and vascular development, because of their ability to target numerous mRNAs, in particular those with similar functions or within related pathways.
A powerful indication for the indispensable role of miRNAs in angiogenesis was shown by EC-or vascular smooth muscle cell (VSMC)-specific deletion of Dicer, an enzyme essential for miRNA biogenesis, resulting in defective blood vessel development and EC function. 5 -7 To date, the exact regulation of angiogenesis by miRNAs has not been resolved, though a handful of miRNAs were shown to stimulate (let-7f, miR-27b, 130a, 210) or inhibit (miR-17, 18a, 19a, 20a, 92a, 100, 221, 222, 320) angiogenesis and regulate vascular development (miR-126) or tumour angiogenesis (miR-15, 16, 17 -92 cluster, 296, 378). 8, 9 Especially, the role of specific miRNAs in non-neoplastic angiogenesis in the adult organism remains largely unexplored. Previously, we have observed that miR-214 is differentially expressed in compensatory arteriogenesis. 10 In the present study, we demonstrate, through modulation of miR-214 levels, that miR-214 is a potent regulator of angiogenesis both in vitro and in vivo. We found that miR-214 directly targets Quaking (QKI), a protein critical for vascular development and remodelling, and regulates the secretion of several angiogenic growth factors like VEGF, bFGF, and PDGF.
Methods
An expanded Methods section is available in the Supplementary material online.
Animals
All experiments were carried out in accordance with the Guide for the Care 
Ingenuity systems pathway analysis
From six miRNA target prediction databases, the top-scoring miR-214 targets were evaluated with the ingenuity systems pathway analysis (IPA) software (Ingenuityw Systems). The most significant miR-214-predicted target-associated network functions and biological functions were identified. 
Cell culture

Spheroid angiogenesis assay
Twenty-four hours after transfection, MEEC spheroids were generated and embedded in collagen (Advanced Biomatrix) containing MEEC-specific cell-specific medium. Sprouting was quantified using ImageJ software (NIH).
Matrigel tube formation assay
HUVECs were transfected as described. The next day, HUVECs were counted and 7000 cells were cultured for 8 h in a micro-slide for angiogenesis (Ibidi) coated with 10 mL ECMatrix TM (Millipore) in 50 mL of EGM-2 containing 10% FBS. HMECs were transfected as described. After 5 h, the transfection medium was replaced by an empty medium containing 2% FBS. Conditioned medium (CM) was collected after 72 h. Ten thousand untransfected HMECs were cultured on 10 mL of ECMatrix TM in a micro-slide for angiogenesis in 50 mL of the CM. Tube formation was quantified after 16 h.
Scratch wound cell migration assay
HUVECs were transfected as described. The following day, HUVECs were counted and plated in 24-well plates. At 90% confluency, a scratch was made and the medium was replaced with EGM-2. Wound closure was measured after 11 h. CACs were transfected with ctrl-miR or pre-miR-214 as described. CAC CM was collected after 48 h and used in a scratch wound assay with untransfected HUVECs. Pictures were made after 7 h.
Cell proliferation and viability assay
Cells were transfected as described, or grown in the CM of transfected HMECs. Cell proliferation was assessed by WST-1 assay (Roche).
Antagomir treatment and Matrigel plug angiogenesis assay
Antagomirs were designed as previously described and customsynthesized (VBC-Biotech).
14 Twelve male C57BL/6J mice (12 weeks old, Charles River Laboratories) per treatment group underwent tail vein injections of 8 mg/kg body weight antagomir at the day of Matrigel injection and 1 and 2 days later. The in vivo angiogenesis assay was performed as previously described. 10 In brief, 500 mL of Matrigel TM Basement Membrane Matrix (BD Biosciences) was injected subcutaneously along the abdominal midline. After 14 days, mice were sacrificed by cervical dislocation and Matrigel plugs were carefully dissected and processed for paraffin sectioning. Five micrometre paraffin tissue sections were stained with haematoxylin and eosin (H&E), or with aSMA and CD31 antibodies and embedded in Fluoromount-G (SouthernBiotech).
Mouse retinal developmental angiogenesis
Postnatal day 2 C57BL/6J mice were fixated and stabilized by hand for intracardial injection. Pups were closely monitored for signs of airway obstruction and distress; 8 mg/g body weight of antagomiR-214 or A. van Mil et al.
ctrl-antagomiR was injected intracardially in three mice per group. After 7 days, mice were sacrificed by decapitation and retinas were dissected and stained with isolectin B4. Capillary density was quantified using ImageJ.
Quantitative real-time PCR
Total, DNA-free, RNA was transcribed to cDNA using the iScript cDNA Synthesis Kit (Bio-Rad), and quantitative real-time polymerase chain reaction (qRT-PCR) was performed on a MyIQ single-colour qRT-PCR system (Bio-Rad).
Luciferase experiments
The conserved miR-214-binding sequences in the QKI 3 ′ untranslated region (UTR) were cloned into the pMIR-REPORT Luciferase vector (Ambion). Seed mutations for target site 1 or 2, or both, were generated by QuikChange Site-Directed Mutagenesis (Agilent Technologies). To determine suppression efficiency of miR-214, HEK293 cells were co-transfected with 200 ng of pMIR-REPORT-QKI-3 ′ UTR Luciferase vector, or one of the mutated vectors and a pMIR-REPORT b-gal control plasmid to assess transfection efficiency. In addition, 50 nmol/L pre-miR-214, a combination of pre-miR-214 and anti-miR-214, or a ctrl-miR was introduced by using Lipofectamine 2000 (Invitrogen). Luciferase and b-galactosidase activity was assessed after 48 h with the Luciferase Assay System and b-galactosidase Enzyme Assay System (Promega), respectively.
siRNA experiments
MEECs were transfected with either 20 nmol/L QKI siRNA, scramble siRNA (Invitrogen), or 100 nmol/L anti-miR-214 (Thermo Scientific) together with 20 nmol/L QK siRNA, using Lipofectamine TM RNAiMAX (Invitrogen). The spheroid angiogenesis assay was performed as described.
Western blot
Equal amounts of protein were loaded, separated by PAGE, and transferred to nitrocellulose membranes (Sigma-Aldrich). Blots were probed with VEGF, TSP1, and GAPDH antibodies.
Antibody array
Human Angiogenesis Antibody Array G1 (RayBiotech) analysis was performed according to the manufacturer's instructions on anti-miR-214-and ctrl-miR-transfected HMEC CM.
Statistical analysis
Data are presented as mean + SEM and were compared using a Student's t-test (Microsoft Excel) or Mann-Whitney U test (SPSS, Inc.). Differences were considered statistically significant when P-values were ,0.05, indicated by an asterisk.
Results
miR-214-predicted targets correlate with angiogenesis-associated functions
In our previous study, we observed the differential expression of miR-214 in compensatory arteriogenesis. 10 To understand the potential role of this miRNA, we analysed only the most significant predicted miR-214 targets of six target prediction databases with the IPA software. The miR-214 target data set entered into IPA yielded an array of functions commonly associated with angiogenesis, like cellular assembly and organization, cellular development, cell-to-cell signalling and interaction, and cell death ( Tables 1 and 2 ). The two most significant network functions, and affected molecular and cellular processes associated with the predicted miR-214 targets, are cellular assembly and organization, and cellular development, both critical in the process of angiogenesis.
miR-214 is highly expressed in vascular cell types
To investigate whether the highly conserved miR-214 (Supplementary material online, Figure S1 ) is indeed present in the vascular system, we examined miR-214 expression in several vascular cell types ( Figure 1A ). miR-214 is highly expressed in several EC types, VSMCs, and vascular fibroblasts (vFBs), but not in CACs. We also observed that miR-214 is most abundantly present in tissues with a vast capillary bed (Supplementary material online, Figure S2 ). Although little is known on the role of miR-214 in the vascular system or angiogenesis, neither under physiological nor under pathological conditions, the expression pattern of miR-214 suggests a significant role for miR-214 in the vascular system.
miR-214 regulates in vitro angiogenesis
To investigate whether miR-214 functionally affects in vitro models for angiogenesis, we overexpressed or inhibited miR-214 in a threedimensional EC spheroid sprouting assay. MEECs were efficiently transfected (Supplementary material online, Figure S3A ) and transfection with either miR-214 precursor molecules (pre-miR-214) or an miR-214 inhibitor (anti-miR-214) resulted in significant miR-214 up-regulation and repression, respectively ( Figure 1B) . Transfection of fluorescent control-miR was performed to confirm that small RNA molecules were still present after spheroid formation and embedding into collagen matrix (Supplementary material online, Figure  S3B ). Cell-to-cell signalling and interaction 2.12E 2 04-3.56E 2 02 56 miR-214 inhibits angiogenesis length, and a reduction in branching, whereas anti-miR-214-mediated miR-214 inhibition resulted in a 40% increase in outgrowth of tubular sprouts and an increase in branching ( Figure 1C ). In addition, we modulated miR-214 levels in a HUVEC Matrigel assay. In this angiogenesis assay, miR-214 overexpression resulted in an inhibition of tubule formation as shown by a significant reduction in tubule length and size, whereas miR-214 inhibition led to an increase in tubule formation ( Figure 1D ). Since EC migration is an essential process of angiogenesis, we assessed the effect of modulating miR-214 levels in a scratch wound HUVEC migration assay, showing inhibition of migration by miR-214 overexpression and an induction of wound closure by anti-miR-214 transfection (Supplementary material online, Figure S4 ). Clearly, modulation of miR-214 expression in ECs can block or enhance vessel growth in vitro, suggesting a direct regulatory role for miR-214 in vessel formation. In addition, we showed that EC proliferation and viability was not affected by modulating miR-214 levels (Supplementary material online, Figure S5 ).
In vivo miR-214 silencing enhances Matrigel plug angiogenesis
Considering the promising effects of miR-214 modulation on angiogenesis in vitro, we assessed the functional involvement of miR-214 in modulating angiogenesis in vivo. To block miR-214 in vivo, we designed so-called antagomirs, which are chemically modified and cholesterol-conjugated, single-stranded RNA oligonucleotides complementary to the specific miRNAs (Supplementary material online, Figure S6A ). 14 We also designed a mismatch control antagomir (ctrl-antagomiR), containing six nucleotide substitutions compared with antagomiR-214 (Supplementary material online, Figure S6A ), which did not match any known miRNA or mRNA. We found that mice treated with antagomiR-214 displayed a significant reduction of up to 98% in miR-214 expression 2 weeks after initial injections (Supplementary material online, Figure S6B ). Other miRNAs were unaffected by antagomiR-214 or mismatch-antagomir treatment, as shown Figure S6C ). We used a Matrigel plug EC invasion assay to assess the effect of miR-214 silencing on in vivo angiogenesis. Consistent with our in vitro data, miR-214 silencing in vivo enhanced the number of invading cells. Although normally only little cell infiltration occurs in growth factor-reduced Matrigel, as shown for ctrl-antagomiR-treated animals, we observed a strong increase in cell infiltration in miR-214-silenced animals (Figure 2A and B) . Additionally, erythrocytecontaining capillary structures were observed in miR-214 knockdown mice only (Figure 2A, higher magnification) . Figure S7A and B) were observed. Moreover, a 3.5-fold increase in vessel formation was shown by CD31/aSMA+ cells that assembled into a primitive, but perfused, vascular network, consisting of ECs surrounded by SMCs ( Figure 2E and C, higher magnification). This increase in plug vascularization by antagomiR-214 demonstrates that miR-214 inhibits angiogenesis in vivo.
miR-214 silencing enhances mouse retinal developmental angiogenesis
Our previous results showed that miR-214 inhibits angiogenesis in vivo. To further explore the functional effect of miR-214 on angiogenesis in vivo, we investigated whether miR-214 silencing could also promote mouse retinal vascular development, a well-characterized and robust model for in vivo angiogenesis. We used antagomirs to silence miR-214 during postnatal retinal vascular development. Retinas were isolated after the first postnatal week to assess the effect on the formation of the vascular network by staining with isolectin B4. We found that antagomir-mediated knockdown of miR-214 levels in the postnatal mice resulted in enhanced capillary density as shown by an increase in retinal capillary length ( Figure 3A and B) . From postnatal day 7 onwards, the retinal vessels start sprouting vertically into the deeper layers of the vascular plexus. Quantification of these vessels showed that this ingrowth was significantly enhanced in the miR-214-silenced mice ( Figure 3A and C ) , suggesting an overall enhancement of retinal vascular development.
miR-214 targets QKI
To get insight into the mechanisms by which miR-214 regulates angiogenesis, we searched for putative angiogenesis-related mRNA targets of Figure 2 In vivo miR-214 silencing enhances Matrigel plug angiogenesis. Effect of (A) miR-214 silencing on cell infiltration as shown by H&E staining and (C) capillary formation as shown by CD31 and aSMA staining. Quantification of (B) cell infiltration, (D) CD31+ cells, and (E) CD31+/aSMA+ capillaries in the matrigel plug. Dotted lines delimit tissue and Matrigel. n ¼ at least 6/group. miR-214 inhibits angiogenesis miR-214. Predicted by four out of six algorithms, having several miR-214 target sites, and given the essential role in vascular development and angiogenesis, its conservation, and its expression in ECs and VSMCs, we identified QKI as a potential direct target of miR-214. 15 -17 We confirmed that QKI is expressed in ECs and VSMCs ( Figure 4A ), and we found that QKI is directly targeted by miR-214, as we observed that the QKI 3 ′ UTR luciferase reporter, containing two conserved target sites ( Figure 4B ), could be significantly repressed after co-transfection with miR-214 ( Figure 4C ). Importantly, mutating both target sequences complementary to the miR-214 seed region relieved the repressive effect of miR-214 on luciferase activity ( Figure 4C ). Although different QKI transcripts exist, they vary only in their 3 ′ UTR lengths and aa-tails, but all hold the conserved miR-214 target sites. This indicates that miR-214 can repress the translation of all major QKI isoforms. Since mRNA targeting by miRNAs can result in translational blockage and also in mRNA degradation, we quantified QKI mRNA expression in HMECs that had been transfected with pre-miR-214 or anti-miR-214. We found that QKI mRNA is down-or up-regulated by two-fold upon miR-214 overexpression or inhibition, respectively ( Figure 4D ), demonstrating a regulation by miR-214 not only by translational repression, but also by affecting mRNA stability. More importantly, QKI transcript levels were up-regulated in different tissues of antagomiR-214-treated mice, indicating that QKI is targeted by miR-214 in vivo as well ( Figure 4E ).
QKI knockdown inhibits angiogenesis and reduces angiogenic growth factor expression
To investigate whether miR-214 exerts its anti-angiogenic actions via targeting of QKI, we knocked down QKI by siRNA in ECs and performed a spheroid angiogenesis assay. SiRNA-mediated knockdown of QKI led to a similar effect on sprouting as shown earlier for miR-214 overexpression ( Figure 5A and B) . A near five-fold decrease in sprout length was observed when compared with scramble siRNAtransfected cells ( Figure 5B ). Co-transfection of ECs with both QKI siRNA and anti-miR-214 could not rescue the negative effect of QKI down-regulation on EC sprouting, as indicated by a significant decrease in tubular sprouting ( Figure 5A and B). It has previously been shown that QKI deficiency and/or loss of function results in decreased vascular endothelial growth factor A (VEGFA) and bFGF expression, respectively. 17 Since VEGF and bFGF are some of the foremost regulators of angiogenesis, we investigated whether the observed effect of QKI knockdown on cellular sprouting angiogenesis could be the result of decreased growth factor expression. Indeed, the efficient knockdown of QKI resulted in the down-regulation of not only VEGFA and bFGF, but also PDGF ( Figure 5C ).
miR-214 negatively regulates angiogenesis by reducing pro-angiogenic growth factor expression and release
Since knockdown of the miR-214 target QKI in ECs resulted in the down-regulation of VEGF expression, miR-214 up-regulation should also lead to decreased VEGF levels. Efficient overexpression or inhibition of miR-214 in ECs (Supplementary material online, Figure S8 ) led to a respective four-fold reduction and 1.6-fold induction in VEGFA mRNA expression ( Figure 6A) . These results could be confirmed at the protein level ( Figure 6B ). Additionally, we found one predicted miR-214 target site for VEGF, but reporter gene analysis excluded the possibility that the decrease in VEGFA levels is attributable to direct targeting by miR-214 (data not shown).
Since VEGFA exerts its pro-angiogenic functions via secretion and subsequent binding to VEGF receptors, we investigated whether miR-214 modulation changes the effect of the CM on angiogenesis. For this, we transfected ECs with pre-miR-214, anti-miR-214, or ctrl-miR and collected the CM after 4 days of culture, which was then used in a Matrigel angiogenesis assay. The CM of anti-miR-214-transfected ECs enhanced HMEC tubular formation on Matrigel by increasing tubular length, the number of branch points, but most prominently by an increase in tubular size, whereas the CM from pre-miR-214-transfected HMECs reduced tubular size ( Figure 6C ). This effect on tubular formation is cell-death-independent since HMEC proliferation and viability were Figure S9A and B). Only after 10 days, miR-214 up-regulation or inhibition resulted in a minor decrease or increase, respectively, in cell number or viability (Supplementary material online, Figure S10 ). To investigate whether the effect on the CM by miR-214 was EC-specific, we overexpressed miR-214 in CACs, a non-endothelial cell, and collected the CM, which was subsequently used in a HUVEC scratch wound assay, resulting in a significant decrease in EC migration (Supplementary material online, Figure S11 ). To further investigate the mechanism by which miR-214 regulates angiogenesis, we examined the secretion of several angiogenic factors in ctrl-miR-vs. anti-miR-214-transfected HMEC CM by protein array analysis. We found that all angiogenic growth factors, including VEGF, bFGF, PDGF, EGF, and IGF1, were up-regulated in the CM of anti-miR-214-transfected cells ( Figure 6D) . Moreover, the secreted, potent anti-angiogenic protein TSP1 was increased by miR-214 overexpression, independent of QKI (Supplementary material online, Figure S12 ). The effect of miR-214 on angiogenic factor release is reflected by the negative effect of pre-miR-214 CM and the positive effect of anti-miR-214 CM on tubular formation as shown in Figure 6C .
Taken together, our study shows that miR-214 inhibits angiogenesis via direct targeting of QKI and reducing pro-angiogenic growth factor release.
Discussion
Here, we have identified miR-214 as a novel regulator of angiogenesis. We have shown, both in vitro and in vivo, that modulating miR-214 levels significantly affects angiogenesis. We found that miR-214 directly targets QKI and thereby negatively regulates vascular growth factor expression and secretion.
miR-214 is located in dynamin 3, opposite strand, a gene that is transcribed into a non-coding RNA, of which the expression is driven by transcription factor twist-1. 18, 19 In line with our previous findings, multiple studies have shown that miR-214 is up-regulated after ischaemia, although in different organs, indicating a tissue-wide role for miR-214 after ischaemia. 20 -22 It is interesting to speculate that the increase in miR-214 after ischaemia might be due to increased levels of HIF1a, which has been shown to directly regulate the expression of twist-1, which in turn is known to regulate miR-214 expression. 19, 23 In vascular disease studies, miR-214 was found to be up-regulated after rat carotid artery angioplasty, suggesting a role for miR-214 in the process of neointimal lesion formation. 24 Additionally, miR-214 was found to be downregulated by the angiogenesis-inducer ginsenoside-Rg1, and modulation of miR-214 levels affected the number of branch points in an in vitro Matrigel assay. 25 However, the in vivo function of miR-214 in angiogenesis has not been explored. In this study, we report for the first time the essential role of miR-214 in the control of angiogenesis in vivo. The high expression of miR-214 in the main vascular cell types, which is confirmed by recent studies showing that miR-214 is present in angiogenic progenitor cells, HUVECs, and human coronary arterial ECs, 26 supports our finding that miR-214 is a regulator of angiogenesis. CACs did not express miR-214, though CACs originate from a monocytic lineage and do not form or integrate into vascular networks. 27, 28 Interestingly, by transfecting miR-214 into CACs, we were able to alter the angiogenic effect of CAC-conditioned medium on HUVECs. Consistent with our hypothesis that miR-214 regulates angiogenesis, in vivo silencing of miR-214 resulted in a strong increase in CD31+ and aSMA+ cell infiltration and capillary formation in implanted Matrigel plugs in mice. The results of our ctrl-antagomiR-treated mice are in agreement with previous reports as well, showing minimal cell infiltration in Matrigel plugs devoid of additional growth factors. 29 The effect on in vivo vascularization in antagomiR-214-treated mice demonstrates the potency of the pro-angiogenic effect of miR-214 silencing, since no cells or antagomiR-214 were added to the Matrigel prior to injection. In addition, we provide evidence of the formation of functional anastomoses with the host vascular system, because the extensive network of luminal structures that is formed in antagomiR-214-treated animals contained erythrocytes. It was previously shown that miR-214 is highly expressed in the developing retina. 20 We could show that, by inhibiting miR-214 during retinal vascular development, the formation of the vascular network was enhanced, indicating a distinct regulatory role for miR-214 not only in adult angiogenesis but also in developmental angiogenesis. The effect we observed on retinal developmental angiogenesis is in support of the evident role of the direct miR-214 target QKI in mouse vascular development. In addition to our used in vivo models to demonstrate the functional role of miR-214 in angiogenesis, it is speculative to think on the use of miR-214 inhibits angiogenesis miR-214 inhibition for the treatment of myocardial infarction. However, since the differential expression of miR-214 is, among others, also related to cardiomyocyte hypertrophy, 30 a clear functional correlation between miR-214 and angiogenesis is not possible. Angiogenesis is a complex process that involves a cascade of events including basement membrane degradation, cell proliferation, migration, assembly and neo-vessel organization, maturation and programmed cell death, which are tightly regulated by cell-cell interactions. Several of these crucial processes in angiogenesis were found to be highly associated with the top-most significant predicted miR-214 targets gathered from six different prediction databases. The two most enriched biological processes targeted by miR-214, namely cellular assembly and organization, and cellular development, are indicative of a more specific role for miR-214 in vascular development and remodelling. Interestingly, multiple studies have identified QKI, validated here as a direct miR-214 target, as a regulator of vascular development and remodelling. 15 -17 Moreover, we found QKI and VEGFA to be present in the top-scoring associated networks, built from each of the six data sets of predicted miR-214 targets. QKI belongs to the signal transduction and activation of RNA (STAR) family of RNA-binding proteins, which bind mRNAs depending on specific motifs, thereby regulating pre-mRNA splicing, export of target RNAs from the nucleus, translation of proteins, and RNA stability. 31 Mouse embryos genetically deficient of QKI die due to severe defects in vascular development and failure of blood circulation in the yolk sac, the earliest site of vasculogenesis and angiogenesis. 15 -17 In general, these studies have shown that QKI plays an important role in proper vascular development and remodelling by regulating interactions between ECs and SMCs. In concordance with these previous studies, we demonstrated that QKI is expressed in ECs and in VSMCs. More importantly, the vascular defects associated with QKI deficiency are reflected by the vascular sprouting defects resulting from miR-214 overexpression and QKI knockdown. By showing that co-transfection of ECs with both QKI siRNA and anti-miR-214 could not rescue the negative effect of QKI downregulation on EC sprouting, we can conclude that the major part of the negative effect seen on EC sprouting angiogenesis occurs through miR-214 targeting QKI. Most interestingly, we and others showed that QKI deficiency results in decreased VEGFA expression, one of the most potent pro-angiogenic factors. 17 In line with these data, we show that miR-214 overexpression results in reduced VEGFA levels, which is reflected by the decreased endothelial tube organization in miR-214 CM-treated ECs. Moreover, silencing of miR-214 increased VEGF levels and VEGF secretion, as well as the secretion of several other vascular factors necessary for normal capillary tube formation. Because QKI is an RNA-binding protein, it is interesting to speculate that QKI might bind to the transcripts of genes involved in vascular development and angiogenesis, thereby post-transcriptionally regulating the expression of these genes. However, we observed that QKI did not regulate VEGFA expression by mRNA binding (data not shown). Nonetheless, it remains possible that the control of VEGFA expression can be ascribed to QKI binding other molecules, like transcription factors. Therefore, we suggest a model in which miR-214 negatively regulates angiogenic signalling via direct targeting of QKI and subsequent reduction of pro-angiogenic growth factor expression and release.
In conclusion, this is the first study to demonstrate the essential role for miR-214 in regulating in vitro and in vivo angiogenesis.
The discovery that miR-214 regulates angiogenic signalling provides a new important target to potentially block pathological tissue growth or to improve therapeutic vascular growth.
